Evidence map›Paper›PMID 38627747›Full record

ArticleRadiation oncology (London, England)2024

Current practices of craniospinal irradiation techniques in Turkey: a comprehensive dosimetric analysis.

Öznur Şenkesen, Evrim Tezcanlı, Fadime Alkaya, Burçin İspir, Serap Çatlı, Abdullah Yeşil, Ebrar Bezirganoglu, Sezgi Turan, Canan Köksal, Gülay Güray and 18 more

Abstract read
In one paragraph

Article in Radiation oncology (London, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Öznur ŞenkesenAcıbadem Mehmet Ali Aydınlar University, Istanbul, Turkey. oznur.senkesen@acibadem.edu.tr.
Evrim TezcanlıAcıbadem Mehmet Ali Aydınlar University, Istanbul, Turkey.
Fadime AlkayaHealth Sciences Institute, Istanbul Medipol University, Istanbul, Turkey.
Burçin İspirDepartment of Radiation Oncology, Acıbadem Adana Hospital, Adana, Turkey.
Serap ÇatlıRadiation Oncology Department, Gazi University, Ankara, Turkey.
Abdullah YeşilDepartment of Radiation Oncology, Medicana Bursa Hospital, Bursa, Turkey.
Ebrar BezirganogluDepartment of Radiation Oncology, Kolan Hospital, Istanbul, Turkey.
Sezgi TuranDepartment of Radiation Oncology, Neolife Medical Center, Istanbul, Turkey.
Canan KöksalDepartment of Radiation Oncology, Istanbul University Oncology Institute, Istanbul, Turkey.
Gülay GürayDepartment of Radiation Oncology, Medikal Park Bahçelievler Hospital, Istanbul, Turkey.
Emel HacıislamoğluDepartment of Radiation Oncology, Karadeniz Technical University Farabi Hospital, Trabzon, Turkey.
İsmail Faruk DurmuşDepartment of Radiation Oncology, Yeni Yuzyıl University Gaziosmanpasa Hospital, Istanbul, Turkey.
Şeyma ÇavdarDepartment of Radiation Oncology, Medicana Ankara Hospital, Ankara, Turkey.
Telat AksuDepartment of Radiation Oncology, Ondokuz Mayıs University, Samsun, Turkey.
Nurten ÇolakDepartment of Radiation Oncology, Kartal Dr. Lutfi Kirdar City Hospital, Istanbul, Turkey.
Esra KüçükmorkoçDepartment of Radiation Oncology, Anadolu Medical Center, Istanbul, Turkey.
Mustafa DoğanDepartment of Radiation Oncology, Trakya University, Edirne, Turkey.
Tülay ErcanDepartment of Radiation Oncology, Gayrettepe Florence Nightingale Hospital, Istanbul, Turkey.
Fatih KaraköseDepartment of Radiation Oncology, Koc University Hospital, Istanbul, Turkey.
Vildan AlpanDepartment of Radiation Oncology, American Hospital, Istanbul, Turkey.
Cemile CeylanDepartment of Radiation Oncology, Istanbul Onkology Hospital, Istanbul, Turkey.
Gökhan PoyrazDepartment of Radiation Oncology, Medipol University Hospital, Istanbul, Turkey.
Nilgül NalbantDepartment of Radiation Oncology, Basaksehir Cam Ve Sakura City Hospital, Istanbul, Turkey.
Şeyda KınayDepartment of Radiation Oncology, Dokuz Eylul University, İzmir, Turkey.
Servet İpekDepartment of Radiation Oncology, Istanbul University-Cerrahpasa, Istanbul, Turkey.
Namık KayalılarDepartment of Radiation Oncology, Acıbadem Maslak Hospital, Istanbul, Turkey.
Hamza TatlıElekta Instrument AB, Barbaros Mah. Begonya Sok. Nidakule, Ataşehir, Istanbul, Turkey.
Mingyao ZhuDepartment of Radiation Oncology, Emory University School of Medicine, Atlanta, GA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis study evaluates various craniospinal irradiation (CSI) techniques used in Turkish centers to understand their advantages, disadvantages and overall effectiveness, with a focus on enhancing dose distribution.

methodsAnonymized CT scans of adult and pediatric patients, alongside target volumes and organ-at-risk (OAR) structures, were shared with 25 local radiotherapy centers. They were tasked to develop optimal treatment plans delivering 36 Gy in 20 fractions with 95% PTV coverage, while minimizing OAR exposure. The same CT data was sent to a US proton therapy center for comparison. Various planning systems and treatment techniques (3D conformal RT, IMRT, VMAT, tomotherapy) were utilized. Elekta Proknow software was used to analyze parameters, assess dose distributions, mean doses, conformity index (CI), and homogeneity index (HI) for both target volumes and OARs. Comparisons were made against proton therapy.

resultsAll techniques consistently achieved excellent PTV coverage (V95 > 98%) for both adult and pediatric patients. Tomotherapy closely approached ideal Dmean doses for all PTVs, while 3D-CRT had higher Dmean for PTV_brain. Tomotherapy excelled in CI and HI for PTVs. IMRT resulted in lower pediatric heart, kidney, parotid, and eye doses, while 3D-CRT achieved the lowest adult lung doses. Tomotherapy approached proton therapy doses for adult kidneys and thyroid, while IMRT excelled for adult heart, kidney, parotid, esophagus, and eyes.

conclusionModern radiotherapy techniques offer improved target coverage and OAR protection. However, 3D techniques are continued to be used for CSI. Notably, proton therapy stands out as the most efficient approach, closely followed by Tomotherapy in terms of achieving superior target coverage and OAR protection.

Indexed as

Craniospinal IrradiationRadiotherapy, ConformalRadiotherapy, Intensity-ModulatedAdultChildHumansRadiotherapy DosageRadiotherapy Planning, Computer-AssistedTurkeyCraniospinal irradiationIntensity-modulated radiation therapyProton therapySecondary cancer riskTomotherapyVolumetric modulated arc therapy

Identifiers

PMID38627747
PMCPMC11022438

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.